Technology | Heart Failure
The U.S. Food and Drug Administration (FDA) has qualified the Minnesota Living with Heart Failure Questionnaire from the University of Minnesota as part of the Medical Device Development Tools (MDDT) program. This voluntary program is intended to reduce regulatory burden for medical device developers and FDA reviewers by qualifying tools that can aid in the development and evaluation of medical devices. Tools qualified by the FDA can be used by the medical device industry to support device submissions, which could reduce time and resources involved in product development.
May 07, 2018
Feature | Cath Lab | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion. This is a mature market that ...
May 07, 2018
Videos | Cath Lab
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have ...
May 07, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Cardiac Diagnostics | Steven D. Freedman, M.D., Ph.D.
In many cases, the diagnosis and management of patients with rare diseases can require the participation of ...
May 07, 2018
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
May 07, 2018
News
Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical AcQMap High Resolution Imaging and Mapping System. The goal of the collaboration is to improve patient care and the physician experience in electrophysiology.
May 04, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Blog
In March, I made a day trip to New York City to receive the 2017 Jesse H. Neal Award for Best Use of Social Media. The ...
May 04, 2018
Case Study | Cardiovascular Information Systems (CVIS)
Balancing high quality care with efficiency — and avoiding unnecessary procedures — is a priority for any hospital ...
May 04, 2018
Feature | Heart Valve Technology | Dave Fornell, Editor
May 4, 2018 — Transcatheter valve technology has been advancing very quickly and the links to aggregated content from ...
May 04, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Womens Cardiovascular Health
May 3, 2018 — The U.S. Food and Drug Administration (FDA) recently announced the availability of a draft guidance for ...
May 03, 2018
Technology | EP Mapping and Imaging Systems
May 3, 2018 — APN Health LLC announced its Navik 3D mapping system is commercially released and in clinical use. The ...
May 03, 2018
Technology | EP Mapping and Imaging Systems
May 3, 2018 — The U.S. Food and Drug Administration (FDA) has granted market clearance for the Abbott Advisor HD Grid ...
May 03, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology | Drug-Eluting Balloons
May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact Admiral ...
May 03, 2018Technology | Intravascular Imaging
May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
May 02, 2018
News | Congenital Heart
Select adult patients born with a single functioning ventricle, and who have undergone a surgical operation called the ‘Fontan procedure’ during childhood, are being enrolled in a new global-first clinical trial. The trial, led by a multi-disciplinary team of heart and lung physicians, will examine the effects of a portable, non-invasive medical device never before tested on patients with this cardiac condition.
May 02, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now